Council for Tobacco Research
1976 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00010849-2859
Related Documents:- CTRMN010849-0887 Deposition of Lorraine Pollice [Deposition of Pollice in the Matter of Allgood]
- CTRMN010888-0889 Scientific Advisory Board Members 1954- [Record of Names of Members]
- CTRMN010890-0892 Curriculum Vitae [St]
- CTRMN010893-0919 Curriculum Vitae [St]
- CTRMN010920-0926 [St]
- CTRMN010927-0938 Curriculum Vitae [St]
- CTRMN010939-0956 Curriculum Vitae [St]
- CTRMN010957-0958 Curriculum Vitae of Dr. Mckeen Cattell [St]
- CTRMN010959-0960 Curriculum Vitae of Dr. Julius E. Comroe Jr. [St]
- CTRMN010961-0974 Curriculum Vitae [St]
- CTRMN010975-0990 Abstracts [St]
- CTRMN010991-1010 [St]
- CTRMN011011-1020 Curriculum Vitae [St]
- CTRMN011021-1056 Curriculum Vitae [St]
- CTRMN011057-1082 Jeffrey Robert Idle Curriculum Vitae [St]
- CTRMN011083-1092 Leon Orris Jacobson, M.D. [St]
- CTRMN011093-1116 Curriculum Vitae [St]
- CTRMN011117-1123 Curriculum Vitae [St]
- CTRMN011124-1126 Curriculum Vitae of Dr. Paul Kotin [St]
- CTRMN011127-1128 Curriculum Vitae of Dr. Clarence Cook Little [St]
- CTRMN011129-1132 Biographical Sketch [St]
- CTRMN011133-1160 Curriculum Vitae [St]
- CTRMN011161-1161 Ctr Mn 011161 Is Unused [Record of Bates Number]
- CTRMN011162-1163 Curriculum Vitae of Dr. Kenneth Merrill Lynch [St]
- CTRMN011164-1166 Curriculum Vitae [St]
- CTRMN011167-1176 Curriculum Vitae Gordon Barry Pierce, Jr., M.D. [St]
- CTRMN011177-1178 Curriculum Vitae of Dr. Stanely Philip Reimann [St]
- CTRMN011179-1180 Curriculum Vitae of Dr. William Francis Rienhoff Jr. [St]
- CTRMN011181-1190 Curriculum Vitae of Gordon Sato [St]
- CTRMN011191-1219 Curriculum Vitae [St]
- CTRMN011220-1239 Curriculum Vitae [St]
- CTRMN011240-1241 Biographical Sketch [St]
- CTRMN011242-1243 Curriculum Vitae of Dr. Edwin Bidwell Wilson [St]
- CTRMN011244-1245 Curriculum Vitae [St]
- CTRMN011246-1274 1956 Report of the Scientific Director [St]
- CTRMN011275-1325 Report of the Scientific Director [St]
- CTRMN011326-1359 1958 Report of the Scientific Director [St]
- CTRMN011360-1396 1959 Report of the Scientific Director [St]
- CTRMN011397-1430 1960 Report of the Scientific Director [St]
- CTRMN011431-1467 1961 Report of the Scientific Director [St]
- CTRMN011468-1499 1962 Report of the Scientific Director [St]
- CTRMN011500-1500 Ctr Mn 011500 Is Unused [Record of Bates Number]
- CTRMN011501-1535 Annual Report of the Scientific Director [St]
- CTRMN011536-1576 Report of the Scientific Director [St]
- CTRMN011577-1619 Report of the Scientific Director [St]
- CTRMN011620-1662 Annual Report of the Scientific Director [St]
- CTRMN011663-1720 Annual Report of the Scientific Director [St]
- CTRMN011721-1765 Report of the Scientific Director [St]
- CTRMN011766-1815 Annual Report of the Council for Tobacco Research U.S.A, Inc. [St]
- CTRMN011816-1870 Report of the Council for Tobacco Research - U.S.A., Inc. 1972 [St]
- CTRMN011871-1871 Ctr Mn 011871 Is Unused [Record of Bates Number]
- CTRMN011872-1921 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN011922-1968 Report of the Council for Tobacco Research, U.S.A., Inc. [St]
- CTRMN011969-2011 1975 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012058-2101 1977 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012102-2156 Report of the Council for Tobacco Research, U.S.A., Inc. [St]
- CTRMN012157-2210 1979 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
- CTRMN012211-2211 Ctr Mn 012211 Is Unused [Record of Bates Number]
- CTRMN012212-2268 1980 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
- CTRMN012269-2329 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012330-2386 1982 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012387-2458 1983 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012459-2533 1984 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012534-2534 Ctr Mn 012534 Is Unused [Record of Bates Number]
- CTRMN012535-2647 1985 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012648-2744 1986 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012745-2844 1987 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012845-2859 Partial Listing of Research Institutions, Ctr Grantees at Those Institutions, and Dates the Grantee Received Ctr Funding at That Institution [St]
- Author
- Ctr
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 006
- UCSF Legacy ID
- mvr30a00
Document Images
nNaRlws vrl-fcL PNUUUC I S cnPll(t HEIa1i is, Mu tK)

!
r---~
rvK.u-..,.e... M. L
r
`
-4

~ IMPIRIM
~vo
. .. . ` 'L'f,.
~
tW a
. , ~.. . _..~....
1976 REI'ORT
o/
TIIE COUNCIL EOR TOBACCO RESEARCII-U.S.A., lae.
TNE COUNCIL FOR TOBACf.O Rt:St:ARfal-U.!{.A., Inc.
110 Ea.l S9t1.91ree1, New Yorh, N.Y. 10022
44

I
SCIENTIFIC ADVISORY IIOARI)
to The Council for Tobacco Rcsearch-U.S A.. Inc.
as of December 31. 1976
SHELDON C. SOMMERS. M.D.. Chairman
Director of Laborator(es. Lenoi 11ill Hospital
Clinical Pro/rssor of Pathology
College of Physicians B Surgeons of Columbia University
New York, New York
RICHARD M. BING, M.D.
Director of Cardiology and Intramural Medkinr
Hunlington Memorial Hospital, Pasadena, California
Professor o/ Medicine
University of Southern California School of Medicine
Loa Angeles. California
JOSEPH D. FELDMAN. M D.
Head. De artment of Immunopathology
Scripps CPnic and Research Foundation
La lolla, California
WILLIAM U. GARDNER. PH.D.
Scientific Diractor, The Council for Tobacco Research-U.S.A., Inc.
E. K. Hunt Pro/essor of Anatonry (emeritus)
Yak University School of Medicine
New Naven, Connecticut
ROBERT 1. IIUEBNER. M.D.
Chief. Laboratory of RNA Tumor Viruses
National Canoer inslitute
Bethesda. Marrlaod
I
I
I
LFON O. JACOBSON. M.D.
Director. The Franklin McLean Memorial Research Institute
Regenstein Pro/essor of Biological Sciences
University of Chka"
Chkato, Illinois
u. AVERILL A. LIEBOW. M.D. 1
u+
~ Pro/rssor of Pathology (emeritus)
University of California School of Medicine
Saa Diego. C.lifornia
, t
HENRY T. LYNCN, M.D.
i Pro/risor and Chairman
Department of Preventive Medicine and Public ltealth
Creighton University School of Medicine
Omaho, Nebraska
HANS MEIER. D.V.M.. Dr. Med. Vct., M.R.S.11.
senior Stae Scientist
The Jackson Laboratory
Bar Harbor, Maine
I.EF W. WATTENBERG, M.D.
Professor of Pathology
IhCartment of Laboratory Medicine and Patnolo6Y
University of Minnesota Medical School
Minneapolis, Minnesota
JOHN P. WYATT, M.D.
Director
Tobacco and Health Research Institute
University of Kentucky
Lexington. Kentucky
9dd.tlfe St.ff .f The Council
WILLIAM U. GARDNER. Prt.D.
Sckatl/ic Director
ROBERT C. HOCKETT, PH.D.
Reaerrb Director
JOHN 11. KREISHER. PN.D. VINCENT F. LISANTI. D.M.D.
Associate Research Director Associate Research Director
DAVID STONE. PH.D.
Astorlare Research Director

0
CONTENTS
Studies Related to ('ardiovascular !)iccascs and Function .... 5
Abstracts o( Reports . . , . ... - . , , , , . . . . 14
Cancer-Rclated Studies . . . . . . . . , . , , 14
The Respiratory System . . . . . . . . . , , , 29
Heart and Circulation . . . . . . . . . . . . . 41
Ncuropharmacolo6y and Physiology . . . . . . . . 54
Immunology and Adaptive Mechanisms - . . . . . - 61
Epidcmiolo6y . . . . . . . . . . . . . . . 64
Active Projects . . . . . . . . . . . . . . . . . 67
Compkted Pro jects . . . . . . . . . . . . . . . . 75
IndeR of Principal Investigators . . . . . . . . . . . . 85
Ldex of Senior Authors . . . . . . . . . . . . . . 86
t
Studies Related to
Cardiovascular Diseases
and Function
Previous annual reports have presented the general plan and rationak of
Council-sponsored sludies of earcirapnesis and the etiology of chronic pul-
rrN.nary disnrders. Their purpose was to provide a framework in which Ihe
rekvance of individual eontribulions would he more easily apparent.
In the present issue, we describe similarly some of our appruaches to study
of cardiovascular diseases and function.
Cardiovascular Dl.e..es
Among Ihe many disorders of the cardiovascular system, those deriving
from progressive alherosckrosis rank On1 as causes of disability and death in
the United Srates. These include heart attacks (myocardiat in/arclion), angina,
slroke, arlerial blockages in the Iirnbs, and some cases of congestive hear/
failure. Hypertension is believed no1 only to accelerate alherosclerosis, but alut
to precipitate acute events In damaged circulatory syslems.
Atherosclerosis is, lherefore, a principal focus of the present discussion
Epidemiology o/ At6ero.clero.ii-Related Di.eo.e.
Numerous epidemiological studies during the lasl 20 years have southt
possible "eauses" (primary or contributory) of the alherosckrosis-relaled dis-
eases. These studies often surnmariud their findings in terms of "risk /aclors "
The "risk faclor" is essenliaMy a statistical concept based upon mathematical
relationships without necessarily any known or established mechanism by which
it might contribute 1o etiolM.
Among the many twch "risk faelora" frequently reported are hypertensinn,
elevated serum choleslerol, diabetes or a prediabelic dialhesis, cillareue smoking.
personality type, Inadequate physical aelivity. and emotional stress. (]enetic
predisposition (e.g., hyperlipoproleinemia, hcxmaysteinemia) is another such
/aclor, both In its own tight and as a conbibut.x to most ur pi>sibly aN of
the olhen. Biochemisls, physiologists, pharmaaologists, psychuk.gisls, and wtKo
scienlists have thus been challenged to /11) the gaps and learn whether. how.
to what eatent and in what kinds of persons each factor might aclually he
operative. The stimulus to eoniec/ure, speculation and hypothesis has Accn
strong, and many scientists have apparently seited the occasion lo lest Ihcu
personal hunctxs in the hope of a hxky strikc. This was entirely Icgilimatr,
but has tended Io produce a weller of (ra`menlary, confusing and inconclusive
observations subjected to speculative projections. Clarifkaiion may come as
cotxrent, integrative I"ia r:metile that can accommodate all the findinp that
prove vdid.
S

I
Cigarette Smoking as a "Risk Factor"
The identification of a"risk factor" can be no more reliahle than the
stalislics on which il is based. Smr+ken selccl themselves from among the
Seneral population on a basis or bases that are little understood Is q legitimate
to c.onspare them with nonsmoker controls as animal esperimcnlers compare
their test animals with genetically identical htter-malcs?
Tobacco use has many variations. both qualitative and quantitative. To
what ealent does voluntary adoption of any particular behavicral pattern
select out a sub-population with innNe characteristics or life-styles that are
linked to cardiovascular disease swceptihilily?
There are many evidences (rons studies of man that genetic predisposition
plays aa important part in delermining which individuals are poter tial victims
of aUetosckrosis-relaled diseases. In several types ot rather e.lreree suscepli-
bilily, the patterns of inheritance have been well established.
Review of the "tisk factors" listed above indicates that most of them are
already knowa to be inlhrenced, it not determined, by heredity.
Studia of sponuneous alcohol cornumption by inbred mice have showa
subslanli.l straia differences in appNite, in behavioral responses and in mela-
bolism. Analogous mane Mudies of spontaneous nicotine and tobacco amoke
Intake have now been inaugurated by a Council grant to learn whether similar
genetic variations occar.
l'aiw Studies
/deetkal Iwins provide the human coumerpart of animals of inbred strain.
S/udies of all like-seaed Iwins in Sweden and Finland are being assisted by
Tle Couneil in an eRorl to determine broadly the relative inffuences of heredity
versus envirronmenl upon the incidence of atherosckrosis-bsed cardiovaseular
diseases. A key slratesy Is to compare the incidence of such disorders in smoking
and non.moking iden/ical Iwins, including symplomalology during life and,
eventuafly, age al death. the primary cause of decease and poslmortem evaha-
lioo of vascular pathology. Non-idenlical, like-sesed twin siblings serve as
owMro4.
Whik the incidence of discordance in smoking practices is low among
IdeNical twiru, an observation that in itself evidences a slrong role of heredi-
tvy influences (even among Iwins reared aparl) in determining Initiation and
maintenance of snaking, the numbers of discordanta are Sreat enough to accrve
b iacrnsingly significant levels In substantial twin populations followed over
a Mrllcienl petiod of tLne. These studies have now been eaended beyond
Identical twins to other rdalives of various defined degrees of consanguinitr.
such as h.lf-aibs and Ihe oRap.ing of twins.
'I1se.w lirneecwssuming iwvesliplinns will require a eonsiderahk induclion
perlod before comprehensive new reports emerele. They may evenlually provide
more direct evidence whether cigarette smoking per re is a truly si`niAeanl
"ri.k factor" in these and perhaps son.e other diseases. They eannN, however,
be erpected to add greatly to elucidation of palhotenie processes or to provide
6
9
methods useful in reducing risks due to biochemical aberratinn% imparted by the
genes from ancestors. For Ihis, other types of rcaearch are rcquired
Cholesterol Metabolism
Another prevakM "risk factor" in epidemiological studies has been "ele
vated serum choleUerd." Contradictory findings over the years suggest that
this concept was an oversirnplificalion, especially since many victims of heart
attacks had no hislory of high ehokNerol levels. That cholesterol is implicalcd
In a/herosekrosis has Seen assurned because mature arterial plaques contain
the steroid both free vtd in combinations. Neverlhekss, long lerm adminis-
Iration of drugs that lavet serum ehoksterol has not been as generally elfeclive
In arresting or reversinZ the process in man as had been hoped.
Accumulating infetmalion about the states of combination of cholesterol
in blood is directing aueetion 1o the several c-hole.terol<ontaining combina-
lions, classified as ehy:onskrons, very low density lipoproteins (VL1)1.), low
density lipoproleins (LOI.) and high density lipoproteins (11D1.). The t Uls
are the major carriers of hlood chokslerd and there are a mrmher of eaperi-
menlal as well as epiderniologieal /Mrdings that an elevated serum level of
VLDI. is correlated with progression of alherosckrosis, whereas ekvaled Hl)1.
is a favorable indicdion.
Thus certain "lipoprotein proliks° are now considered by many to he
better indicators of susceptibility /o atherosclerosis than elevated total chrd-
esterol. Certain of these prollks, associated with very high susceptibility to
disease, have been showw to be lIeneticaM)f dNermined.
tfarring some unforeseeable empirieal discovery (which does occur in
medical research and is a perennial hope). the rational route toward effective
control is through systematic study of the palboWneais of alherosckrosis, at
biochemical and physiob&al kveb. This obviously must include a heltcr
understanding of the regulalion of synthesis, lransprxl, tunctiun. and elimin
ation of cholesterol and of the aberrations in disease in the hope of altering
these by targeted treNmenl.
The Council is presently reviewing the mosl promising u.ncepls and kads
that now esisl in this eompka field with the intent of increasing its suppoft
of basic study of athererosckrosis. The inlent is not only 1o assist these im-
porlanl devek+prnenls, but also 10 seek more directly relevant assay systerns
for assessing the possible effects of cigarette smoke inhalation.
The task Is additionally diflleuH beeause the atherosckrotic disnrders
appear to be peculiarly human ones with few eounlerparts among animals
under natural eorditions. liighly contrived manipulations to produce animal
"oounlerpart:' tend 1o diminish probability of relevance to hrrman esperience
Iluman studies have been impeded by the lack of non-interventiwns tech-
wiques for assessing iniliNiow and prolresswn of the atherogencsis processes
in the vasculalure of man. New eaperimental techniques tor visualizing the
condition of the arterial walls, iecluding scintillation photography, appear ar
ahow promise for the future.
T

In Vitro Studies o/ Arteriei and Vein.
Meanwhile, in vitro techniques provide one method of sluJying synthesis
.rd uptake of lipids and cholesterol by human arteries and veins, both
"normal" and atherosckrolic, in direct comparison with those of .nimais.
Though in virro conditions cannot be made to duplicate the in vivo situation
perfeclly. they may provide useful guides to in vivo research.
Such studies have already been asade with CTR support as described in
the Council's Annual Reports for 1972-1973. 11 has been reported (and is
reiterated in a current review) that human .Iherosckrotic and nornNl coronary
arteries as well as sapheswus veins, perfused under puls.lik .rler.l pressures
M(h human plasma containing labeled cholesterol and acetale, do not synthe-
site cholesterol from aeetale and produce only small .mounts of cholesterol
eqers. Choksterd is laken up in Identical amoums by norm.l and diseased
vessels .nd Ihis uptake is increaaed at higher pulse pressures, s.hkh seems
eonsiMant with the reputed effects of hypertension. Labeled acetnle is Incor-
porated In1o various lipids. both normal and diseased coronary rlerks and
saphenous veins synthesize free /atly acids, triglycerides and plwspholipids.
Addition of nicotine to the perfusion fluid did not influena' cholesterol
uplake. Analogous esperinxnls with dog arteries appeared to shown .n In-
fluence of nicotine upon choiesterol uptake. If this is confirmed. iI wttlests
caution M estrapolations from this species to man (1972 reporl ).
Carbon rna+oside In the perfused plasma was reported to euhanee ehol-
ealerd uptake by afl arteries in this in vitro system.
Several new studies report a dramatic inhibition of cholesterol uptake by
both human and animal arlcrks, under these in vitro eoeditions, by 7-keto-
ehoiesterof.
Living rabbits also showed an inhibition of cholesterol uptake. hul to a
much snsalkr eslent. TAe low solubilily of the 7-keto compound imposed
teehnk.l problems. Improved techniques may increase the efficiency of the
tRect. Meanwhik. the disparity between the in vitro and whole animal te-
sponan is another resninder that eatrapolations must be cautious.
Other current studies deal with elucidation of possible mechanisms of
the Inhibition and with the metabolic /Ne of the injected 7-keto compound ht
rabbits.
Role o/ Smooth Mu.c/e Cells in Athero.clerotie Plaque.
TAe heretofo.e prevaknl theory of alherosckrotic plaque formation postu-
lated that the inflhrNion of (atly substances from the bloodstream inlo the
arterid wall gives rise to cholesterol deposits that act as an Irritant, causing
In/lammation and proliferation of cells by processes akin to ordinary healing.
This "itnudalion" concept was eondstenl with the associations of atherosckr-
oda with elevated blood chokslerol, high blood pressure and high lat diets.
Animals fed large amoun/s of .aturaed f.ts snd cholesterol. sometimes sup-
plrmenled with Iw.nmun.l rw other 1reNmenlt, devek.ped (imirms superfki.lly
re.emMrns th...r .+.vr.rd in man 1 aa.trqav 7 he.e lesions often regressed
In snrm.l %tr. rn. drro oo,e.e atr.-/ n ~ 1.urvarun that stimulated human
dretarr wul.r. rn..a..n~ re.u,r.e.rr ..f atr-IrNer,d snd saturated fat eonsump-
r
Iion. Complicated by difficulties of conlrol, the results in man have been
equivocal.
Recent electron microscopic studies of human arterial plaques have re-
veakd that the major component of authentic playucs is proliferating smtwnh
muscle cells like thrne normally composing the center 1 medial ) layer nf arter-
ial walls rather than 6brohiasl cells such as pradiferate to heal a wound. l:arly
human arterial lesions (streaks) contain Ii111e lipid. sugResling that insudalion
is not the prime factor in typical atherosclerosis. Choleslerol .kptnits and
cellular debris appear later. Present debate centers on what incites normal
smooth muscle cells to migrate from the medial layer and what causes them
to proliferate. Presum.bly, damage to the inner surface cell layer of the
vessels is implicated and a number of theories as to how this endrHhelial layer
may become damaged have been advanced.
Many of the plaques generated In animal arteries by n..r-physiological
manipulations are reported to be radically differenl in composition Irom those
of genuine human atherosclerosis .nd their relevance to the human diseases is
therefore questionable. Recognition of the difference has, however, led to
reporta that certain animah can develop human-type atherosclerosis under
other more appropriate conditions.
Snaolh musck eeYs from primate arteries are now being maintained
successfully in culture media. Low-density lipoproteins added to the media
stimulate them to multiply. FtMher, il has been reported that the ever-present
blood plalelels, normally involved in Ihe clotlin6 process in response to injury
and in other functions, ahio secrett a substance that strongly stimulates pro-
liferalion of Ihew smooth muscle ee11s. Damage to etsdcNhelial and inlimal
cell layers of an artery, which ordinarily separate the bhxxl from contact wilh
the smooth muscle cells of the medial layer, can bring the.e cells into contact
with platelets and presumably Ineite multiplication in the artery wall.
Another concept holds that the snsoMh muscle cells mulliply as the
consequence of a mut./ion akin to that which transforms other normal cells
into malignant ones. This `nsonocbeaP' Iheory, which is supported by suikin6
evidence but is neverthekss in sonse dispute, would suggest quite diRerent
mechanisms of action by e.lernd agents than those describcd heretofore
Endothelial C.lti and Blood Plateleta
A single layer of endotheliat cells eomposes the thin memhrane lining
the inner surfaces of arleries, performing an important function in relainrnt
the red napuscks while allowing waer and s.ame other suh.taoces to pass
throuth. As mentioned, damage to the endaMhchum is heGeved t+r crrntnhua
to all three of the snechanisms of atherosclerosis described. Many p.nubtc
causes of endothelial damage have been auRRestcd and are being sturlied
It is possible that several may be involved. '1 he damaeed enduthelium can
repair itself, rather slowly. but if damage is sustained ar repeated uw often.
repair may mN he achieved.
(.'lots (Ihrombi) forming in an artery are thuuRht tu in/urc Ihe endo
thelium by pressure and by impeding the access a/ oxyRen "1 he hl.wxl plNelets
have long been- known to play a role in the ctNnplet events that produce
9
0

tbrrxnbosis ie both arteries and veins, and may thus contribute indirectly to
endothelial injury. At Ihe aame lime, it has been thought likely that the plate-
kts may contribute In some way to maintaining integrity of the endothelium.
Recently developed Iechniques for growing human endothelial cells in
culture media, a(ler harvest from umbilical cords, have made it possible to
study tacion that influence their replication. A Council-sponsored investigator
has reported that platelets added to the medium, as well as some individual
subslasces secreted by the platekts, will slimulate their growth. It is, therefore,
suggested that !n v/.o, platelets may espedite endolhelial repair. !le has also
Irolated from normal blood substances that inhibit platelet adhesion and thus
itnpede the processes of thrombus formation. The implication is that a delicate
balance among opposing (unctions maintains inlegrity under normal conditions.
Estensbn of such studies should help delineate the mechanisms of throm-
boaM and atherosckrosis.
Another inve.titator has used /w vitro techniques to cuilurr, nt heart
wNrele atsd epithelioid cetb /o determine the effects of chokslerd, choksterol-
e+less and 6-lipoprwein in producing cellular lipid inclusions and in labilizing
}yaowera or mitochoe8ria.
Lreldhins Cholesterol Acy/ Tr.ns/er.se (LCAT)
Leeilhin: cholesterol acyl transferase is an enzyme thought to be respon-
dbie for the esteriAcalinn of lipoprsxein cholesterol in plasma. It i! postulated
by seret.l inveMitalon to be important in the mechanisms that renave chol-
~MOrol frorn the arterial wall.
A number of previous papen, abslracted in these Annual Reports, have
reported dinkal studies of 1.('AT activity in the plaswra of animals and maw
sder diRerent circumstances to elucidate its clinical significance. Instability
of the estrytwe oomplkaled Ihese studies. E.perimentation to delineate the
Mtyswe's wsodes of action required its isolation. purification and stabilization
so dmt en:ya+e oooeenlrations could be controlled and substrate compositions
betw defined.
A reoent publication reports that a concentrated effort has achieved the
Iadatiow of LCAT in substantial quuuily in a virtually pure state with greatly
Irnproved stability. Development of a radioimmunoassay Is reported to be
under way. Two publications on applied studies of LCAT have also appeared
reoealti.
Availability of the purified enzyme and of i1s radioirnmunoassay should
sUmulata and facilitate studies of choksterol metabolism and the roks of the
se.esd lipoprolcins and contribute to understanding of atherosckro.is.
Massbolic Actioities o j Puln.otaary Endot/te/iel Ceils
Pive years of research assisled by The Council have produced nunserous
reporta on this subietl. including several published during (976 It has been
,howw that the vasnacsivt potypepUdes bradyhinin and angirAensin I are mtla-
bolkdly alsned durrnt a single passage IhrrMith the vast pulrm+nary, vascular
bed Bradykimw. a s+.b.taece that tends to lower blood pressure, is completely
inactivated while ansiotenein 1 is converted to an6iotemin 11. which is a potent
hypertensive agent. Bradykinin, under suitable conditions, can inhibit this
antiotensin conversion. These relationships suggest a role of the pulmonary
circulation in blood pressure regulation.
These metabolic changes have been traced to peplide hydrolase enzymes
of the lun`, which are not present in the bioodstream but are attached to Ihe
luminal surfaces of endothelial eells, especially those of capillaries and venuks
The same enzyme inaclivates bradylinin and converts ansiolensin 1. Steps in
the hydrolytic process have been described in considerable detail; antiirxiia
lo the enzyme were prepared and labeled to provide lools (or research.
New functions of bradytinin are now being discovered, including an effect
on prostatlandin synlhetase which remains to be esplored in depth It also
remains for future studies to Inquire how dysfunclions of these systems may
be related to vascular or puhno..ry, diseases.
Chronic Smoke Inad.tion by Doss
A technique for chronic eaposure of beagle dogs to cigarette smole via
tracheostomy was employed by a CourKtil-supported scientist to took for possi-
bk effects on clotling snechawisrns and on cardiovascular function. ikspite
recognized IimitNiom ol this technique as a nwQel of human practice, rather
e.tensive eaperieece wN,h i4 use for other purposes suggested that e.tension
of observations to the cardiovascular system might provide some preliminary
data and guidelines (or twure .ludies.
No dinically evident dise.se was towrd at/er 1s months' eaposure under
different dietary regirnes. Some Indications of possible enhancement of coatu
1alion mechanisms and of relatively minor alterations in function were re
porled. The author described these minutely wilh cautions against transfer to
man in view of eaperisuealal limilalioru, pecies dilferenees, and Ihe treater
tbrnpkaNy of human e.viroament..'
Studies Innotrins Nleotiwe
A number of prW Couneil-sponsored studies, mainly using animals and
with a variety ot objectives, have invo(ved the administration of nkotine.
Eaperience through the yean wuests that comments on sorne of Ihe problems
involved In selection of dosages are pertinent lor evaluati.ns of past results
and for designing new and better esperimenls.
SmoMers receive nicotine by way of the oral cavity and Ihe luns, in irnolf
successive doses over a period of several minutes and repealed at variahle
intervals. The entire dosage range they etperience is very low in conlras/ to
the levels often used by pharmacologisb in e.ploratory studies of mcoNne's
pharmacological potentials. The view has been e.pressed that ordinary smut-
ing rarely. U ever, produces high enough levels to act upon the sympathetic
ganglia, but slimulates only the several special sensory receptors to incite raprd
but brief systemic responses of re(ka origin 7hese responses may be quite
contradictory and paradoaical in nature, depending on the conditions that
ptedomioate at any moment.
11
10

Yet, within the low range of dosages that can he achieved from smokint,
there is still very considerable variation Rate of absorption via oral cavity or
lung is highly dependent upon the acid-hase balance in Ihe smoke. Maintenance
of blood level is strongly aRected by the hydrogen-ion concentration of the
bladder contents. The detree of acidity influences nicotine rewrption and is
altered by diet and nervous state. Nicotine metabolism is rapid and melabolic
rates not only vary markedly among normal humans but are probably in-
fiuetsced by duration of smoking esperience, a recognized but little understood
phersoexnon.
In addition are the variations due to choice of tobacco product used .nd
Individual diRerences in puff volume, puff /rerauency, depth of inhalation.
duration of snsoke retenlion, etc.
Design of animal esperi.xnts intended to mimic human smoking e>t-
perience, long or short, must include consideration of .11 the factors enurner-
ated and species diflereeces as well.
EaperimeMal control or Mandardiralion of all the variables mentioned in
any large-acak or /ong-continued human study appears to be virtually im-
posibk. However, an eapan.iors of information on the actual ran" or dura-
tions of plasma nicoline levels attained by human smokers (and users of other
forms of tobacco) under actual conditions of life should be attainable.
Recent studi.s by laborious snethods have provided such data for small
sumbers of human subjecls. These are a most valuable interim guide to the
daign of animal esperimenls However, mass data on large representative
populations are needed to de/lne, on a sound atatistical basis, the ranges, peaks
and medians of plasma nicotine on a time scak, if important refinements are to
be achieved in epidemiological studies of smoking.
R.dioinswsunological A..ay o/ Nicotine
Sensilive, specific and rapid assays for plasma nicotine and its major
metabolites have long been needed. They should be able to he carried out with
very small samples of blood. with simple. inespensive and mobile epuipmenl,
and by competent technicians without etaraoadinary special Iraining, have long
been needed for such purposes.
Rad'aimmunoass.ys would appear to have promise of meeting these re-
quiremenls and The Council is continuing to support studies in this area.
Antibodies sensitive to nicotine have heen obtained and report.d t1973)
Continuing ellorts are now directed toward improving sensitiviq, testing for
specificity and simplifying procedures for broad applicalion.
Nicotine Bffecfa on Coronary Circulation in (:on.cioua noR
To avoid the eRects of anesthelics on the pharmacobRical r.sponses to
nieoline, a merhrxf was perfected lor imracar.rlid adminidratiun of the alka-
loid to conscir.us do`s in doses de.cribed by the investigator as "realistic."
A striking increa.e rn cor(Mary hhM.d flow was oh.erved which was (raeed to
Iwo separate /actars Tbe marx component was found to he due indirectly to
+
an increase in the depth of respiration produced by nicotinc. Ihe minor one to
a chemorefiea via a different pathway.
F.PIDF,AIIOI.OGIC STUDY OF SiU)KIN(: Ct:SSATION
A general difflcully in making and interpreting studies of smoking cessa
tion is that those who discontinue smoking are not cMnen at random hul by
their own decision, so that the influence of acleclion on comparafahly of the
groups has been unknown. Nor has it generally been possible to as.css the
influences of concomitant or "eompensalory" changes in life-stylc, such as
alleralions in dier, eaereise, use of akohesi or drusa. etc.
A Council-spunsored eomparison of continuing snwskers, with smokers
who have disconlinued, and with smokers who have stopped /rK a periwd and
then resumed, sometimes repeatedly, is under way. In the population under
sludy, a large body of data had been collected by uniform methods when all
were smokers, before any had Mopped. Hence, some bases may be found lor
assessing selection biases that rn.y have occurred in the aubsequent groupings
into the calegories mentioecd.
12

j
Abstracts of Reports
Following are ahsuacls, approved by the aulhon, of reports on new re-
search acknowkdgin` support (rom The Councit that have sppeareJ in scientifk
}ournals since publication of the 1975 Report. 1 he name of the recipient is
in ilalics. ~
The abstracts are grouped under these headingi: 1. Cancer-Rclated Studies.
(1. The Respiratory System. 111. Heart and Circolation, IV. Neuropharn-ucolosy
and Physiology. V. ImmunolM and Adaptive Mechanisms. VI. Epidemiology.
1. Cancer-Related Studies
HYDROCARBON-NITROSAMINE SYNE:R(31SM AS A POSSIBLE
AMPLIFYINO FACTOR IN LUNO TUMORIGENESIS BY
TOBACCO SMOKE
A number of studies have shown that inducers and repressors of microsomal
miaed-funetion o.idases can powerfully inlluence the eflecls of chemical ear-
einopens. A significant incidence of pulnwmary tumon has been reported in
both rats and mice as a result of the simultaneora administration of )-metfiyl-
eholanthrene (MC) and dimelhylnilrotamine (1)MN) at levels at which neither
compound h carcinogenic in the lung Nittosamines, including DMN, as well as
7,1-bentopyrene and ),1-bentoAuoranthene whoae carcinogenic properties are
very similar to thosc of MC, are present in tobacco snwke. Therefore, it is pro-
posed that a substantial proportion of the lung tumor incidence of sn.okers is
due to synergism between the carcinogenic hydrocarbons and nitrosamines in
the smoke, rather than to hydrocarbons alone. Two alternative tnechanisms
which may account for this synerlism are considered. Preliminary results, how-
ever, support the concept that DMN increases the hydrocarbon epoaide pool by
lowering the activity of microsomal eposide hydrases In the lung while substan-
tially Increasing the arylhydrocarbon hydrosylase activity. The demonstration
of a DMN-hydrocarbon synergism in human lung earcinobenesis could tn-
oours{e uneapbred approaches for the development of partial means of pro-
Ieclion for smokers, such as the use of DMN-dcmelhylase repressors and in-
hibibrs to block the DMN-hydroearbon synergism. It is also suRgr.tcd that
dietary nitrosamines or prenitrosamine components, such as nNrites anJ secon-
dary amines, may be found to have sorne role in the etiology of lung cancer.
Argus, M. F. and Arros. 1. C.
Iorrnd of 7Aro.eN,d d/oloffy 36:491-1911, 1976.
Other support: National Cancer Institute.
From the Seamen's Memorial Research I ahnratory, I1. S. Public Ileallh Service
11npital, and the Uepartment of Medicine. lulane University Medical Center,
New Orleans
1
SIRU('IURAI. I.IMIIS OF SPF.CH'1('ITY OF
MEIIIYI.('ll()LANIHRENE-REPRES.SIBI.E NIfROSAMINI
N-VEALKYLAStS. INHIBITION BY ANALO(: SUBSIRAII-s
In order to gain sn insight into the structural specificily of durNthyln,tru,..
mine (DMN)-demethylase, a systematic investigation was carrrcJ wn ,ar lhe
cnMnparative dealkylation of DMN, higher diatkylnilrosamines and DMN .n.,
k+ts, as well as on the inhihilion of DMN-demethylatiun by the DMN ,nawgs_
Other e.periments in this framework eapbred the eQec1 of pretreatnknt by 1.
mcthyl choianthrene (MC). a potent repressor of DMN-demcthylase, on th..e
different dealkylases. Resuhs showed that the dealkylation of dimethyl-. drcthy6
and dipropylnilrosamine by hepatic microsomes of Sprapre-Dawky rats was
tepreaseJ by pretreatment of the anirnah with MC. 7his repression prolus.
sively decreased with the Increase d.Ikyl chain length. In conlrast trr iti effect
on Ihe demethylation of DIKN. In viro phenoharhital induced rathet than re-
pressed the deethylation of dielhylnitrosamine (DEN). lhe rates of dcmcthyla
lion of the DMN analog subslrales, although low as compared to 1)MN, in.
creased with the acyl chain length. These analogs were potent in virro inhibaon
of DMN demethylation when tned in combination with DMN as substrates,
and the inhibition decreased with the length of the acyt chain. Although the
rate of demethylation of inelhylphenylniuosamine was not influenced by M('-
pretrestmenl, tine compound was, however, a potenl inhibitor of demelhylalion
when used as substrate in combination wilh DMN. Moreover, beyond the ap-
parent distinctness of DMNdemelhylase and DI:N-deethylasc there is now in
dication that more Ihan one en:yme, having the same substrate specificity but
different kinetic and regulatory eharaeleristics, underlie DMN-demethylase ac-
tivity.
Arcot, /. C. et e/.
Zeirscibi/t Jiir KrebiJo.xArnP nnd It`lin/iche OnAotoRie e6:171-at), 1976.
Otller ur'prtr National Cancer lmtilwe.
From the Seamen's Memorial Research l.aboralory, U. S. Public lieal,h Service
Hos pilal, and the Department of Medkine, Tulane University Medical ('enler.
New Orleans.
DIMETHYt.N11ROSAMINE-DEMETl/Y1.ASli: ABSEN( E 01;
INCRI?ASEI) FN7.YME ('ATABO1 ISM AND MI)1 1/1'1 1('I I Y(1F
EFFE('fOR SIIES IN REPRI:SSIUN. Hh.MUIROII-IN INVUI VIMI NI
Evidence is presented here that Ihe rate ot decay of Jimcthylnirru.anminc
(DMN)-dernethylase following pretreatment with )-merhykhol.rnrhrene (Mt )
is no greater than that so be eapetled (rom rnuoul enryme cat.Mrlism '1 hrse
results also show that the observed decrease of 1)MN dcmethyl..e V,,,, Iolluw
inb MC administration is rat due to increascJ rate of breakdown MN to dc
crea.ed Aa, novo synthesis. Other eapcrimenb in this study inJiaare that dr/fcr
eet receptor sites are involved in the repressinn of I)MNdemethyla.e by hydru
carbons and by phcnobarbilsl (PB), and that a P-ISI) type nuarosnmal cyto
chrome is involved in the demethylalinn of UMN. lhe totality of these e.
petimental observaliona presents an apparent patadoa which may tic aummar-
